Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Gray Sheet

Executive Summary

Delay in Health Insurance Portability & Accountability Act electronic standards' October 2002 compliance date is unlikely to pass Congress, HHS Secretary Thomspon said Sept. 27 at a National Association of Manufacturers meeting. The Senate Finance Committee is seeking a one-year delay in transaction and code set implementation only, but any delay is opposed by Sen. Kennedy (D-Mass.) because it may also push back privacy regs. A March bill to replace the privacy rule (HR 1215), introduced by Rep. Greenwood (R-Penn.), has been referred to the House Judiciary/Crime Subcommittee

You may also be interested in...

Data Protection Directive Transitional Relief Period Ends Oct. 24 For UK Firms

UK-based medical device manufacturers are awaiting approval from the Office of the Information Commissioner before circulating a "code of practice" on the European Data Protection Directive, major parts of which become effective Oct. 24.

Merz Consumer Care Optimistic About Future As German Lockdown Continues

Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts